Efforts to elicit broadly neutralizing antibodies (bNAbs) against HIV-1 require understanding germline bNAb recognition of HIV-1 envelope glycoprotein (Env). The VRC01-class bNAb family derived from the VH1-2*02 germline allele arose in multiple HIV-1–infected donors, yet targets the CD4-binding site on Env with common interactions. Modified forms of the 426c Env that activate germline-reverted B cell receptors are candidate immunogens for eliciting VRC01-class bNAbs. We present structures of germline-reverted VRC01-class bNAbs alone and complexed with 426c-based gp120 immunogens. Germline bNAb–426c gp120 complexes showed preservation of VRC01-class signature residues and gp120 contacts, but detectably different binding modes compared to ma...
VRC01 broadly neutralizing antibodies (bnAbs) target the CD4-binding site (CD4 BS ) of the human imm...
VRC01 broadly neutralizing antibodies (bnAbs) target the CD4-binding site (CD4 BS ) of the human imm...
Background: A large number of anti-HIV-1 antibodies targeting the CD4 binding site (CD4bs) on gp12...
Efforts to elicit broadly neutralizing antibodies (bNAbs) against HIV-1 require understanding germli...
Efforts to elicit broadly neutralizing antibodies (bNAbs) against HIV-1 require understanding germli...
Efforts to elicit broadly neutralizing antibodies (bNAbs) against HIV-1 require understanding germli...
Efforts to design an effective antibody-based vaccine against HIV-1 would benefit from understanding...
A large number of anti–HIV-1 antibodies targeting the CD4-binding site (CD4bs) on the envelope glyco...
SummaryElicitation of broadly neutralizing antibodies remains a long-standing goal of HIV vaccine re...
Vaccine candidates for HIV-1 so far have not been able to elicit broadly neutralizing antibodies (bN...
Vaccine candidates for HIV-1 so far have not been able to elicit broadly neutralizing antibodies (bN...
Efforts to design an effective antibody-based vaccine against HIV-1 would benefit from understanding...
The HIV-1 envelope (Env) glycoprotein binds to host cell receptors to mediate membrane fusion. The p...
The HIV-1 envelope (Env) glycoprotein binds to host cell receptors to mediate membrane fusion. The p...
VRC01 broadly neutralizing antibodies (bnAbs) target the CD4-binding site (CD4 BS ) of the human imm...
VRC01 broadly neutralizing antibodies (bnAbs) target the CD4-binding site (CD4 BS ) of the human imm...
VRC01 broadly neutralizing antibodies (bnAbs) target the CD4-binding site (CD4 BS ) of the human imm...
Background: A large number of anti-HIV-1 antibodies targeting the CD4 binding site (CD4bs) on gp12...
Efforts to elicit broadly neutralizing antibodies (bNAbs) against HIV-1 require understanding germli...
Efforts to elicit broadly neutralizing antibodies (bNAbs) against HIV-1 require understanding germli...
Efforts to elicit broadly neutralizing antibodies (bNAbs) against HIV-1 require understanding germli...
Efforts to design an effective antibody-based vaccine against HIV-1 would benefit from understanding...
A large number of anti–HIV-1 antibodies targeting the CD4-binding site (CD4bs) on the envelope glyco...
SummaryElicitation of broadly neutralizing antibodies remains a long-standing goal of HIV vaccine re...
Vaccine candidates for HIV-1 so far have not been able to elicit broadly neutralizing antibodies (bN...
Vaccine candidates for HIV-1 so far have not been able to elicit broadly neutralizing antibodies (bN...
Efforts to design an effective antibody-based vaccine against HIV-1 would benefit from understanding...
The HIV-1 envelope (Env) glycoprotein binds to host cell receptors to mediate membrane fusion. The p...
The HIV-1 envelope (Env) glycoprotein binds to host cell receptors to mediate membrane fusion. The p...
VRC01 broadly neutralizing antibodies (bnAbs) target the CD4-binding site (CD4 BS ) of the human imm...
VRC01 broadly neutralizing antibodies (bnAbs) target the CD4-binding site (CD4 BS ) of the human imm...
VRC01 broadly neutralizing antibodies (bnAbs) target the CD4-binding site (CD4 BS ) of the human imm...
Background: A large number of anti-HIV-1 antibodies targeting the CD4 binding site (CD4bs) on gp12...